174 related articles for article (PubMed ID: 26725649)
1. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.
Hu X; Fan W; Yu Z; Lu Y; Qi J; Zhang J; Dong X; Zhao W; Wu W
Nanoscale; 2016 Apr; 8(13):7024-35. PubMed ID: 26725649
[TBL] [Abstract][Full Text] [Related]
2. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles.
Yu Z; Fan W; Wang L; Qi J; Lu Y; Wu W
Mol Pharm; 2019 Dec; 16(12):5013-5024. PubMed ID: 31638827
[TBL] [Abstract][Full Text] [Related]
3. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.
Yu Z; Fan W; Wang L; He H; Lv Y; Qi J; Lu Y; Wu W
Biomater Sci; 2019 Oct; 7(10):4273-4282. PubMed ID: 31407729
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
[TBL] [Abstract][Full Text] [Related]
5. Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers.
Hu X; Zhang J; Yu Z; Xie Y; He H; Qi J; Dong X; Lu Y; Zhao W; Wu W
Nanomedicine; 2015 Nov; 11(8):1939-48. PubMed ID: 26187556
[TBL] [Abstract][Full Text] [Related]
6. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery.
Liu C; Liu D; Bai F; Zhang J; Zhang N
Drug Deliv; 2010 Jul; 17(5):352-63. PubMed ID: 20387993
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
9. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
Qi J; Lu Y; Wu W
Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
[TBL] [Abstract][Full Text] [Related]
10. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
12. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.
Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241
[TBL] [Abstract][Full Text] [Related]
13. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
[TBL] [Abstract][Full Text] [Related]
14. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
Wang F; Cao J; Hao J; Liu K
J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
17. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity.
Yang T; Sheng HH; Feng NP; Wei H; Wang ZT; Wang CH
J Pharm Sci; 2013 Dec; 102(12):4414-25. PubMed ID: 24166599
[TBL] [Abstract][Full Text] [Related]
18. Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats.
Shi LL; Xie H; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Mol Pharm; 2016 Aug; 13(8):2667-76. PubMed ID: 27379550
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
Fan T; Chen C; Guo H; Xu J; Zhang J; Zhu X; Yang Y; Zhou Z; Li L; Huang Y
Eur J Pharm Biopharm; 2014 Oct; 88(2):518-28. PubMed ID: 24968819
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals.
Neves AR; Martins S; Segundo MA; Reis S
Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
